Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$53.80
-0.98-1.79%
Pre-Market: Mar 14, 4:25 PM EDT
Comments
Loading...
Protagonist Therapeutics Stock Price, Quotes and Forecasts
PTGXNASDAQ
Protagonist Therapeutics (PTGX) Forecast
NewsEarningsProtagonist Therapeutics (PTGX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Protagonist Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PTGX | Benzinga
Explore Protagonist Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PTGX.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Protagonist Therapeutics (PTGX) stock?
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Who are Protagonist Therapeutics (PTGX) competitors?
Other companies in Protagonist Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Protagonist Therapeutics (PTGX) stock?
Protagonist Therapeutics has a consensus price target of $56.75.
What is the current price for Protagonist Therapeutics (PTGX)?
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $53.7972 last updated March 14, 2025 at 4:25 PM EDT.
Does Protagonist Therapeutics (PTGX) pay a dividend?
There are no upcoming dividends for Protagonist Therapeutics.
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Protagonist Therapeutics (PTGX) going to split?
There is no upcoming split for Protagonist Therapeutics.
What sector and industry does Protagonist Therapeutics (PTGX) operate in?
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.